Corrigendum to 'Acquired resistance to the 16-membered macrolides tylosin and tilmicosin by Mycoplasma bovis' [Veterinary Microbiology 168 (2014) 365-371] Doi 10.1016/j.vetmic.2013.11.033;Acquired resistance to the 16-membered macrolides tylosin and tilmicosin by mycoplasma bovis

Veterinary Microbiology

Volumn 168, Issue 2-4, 2014, Pages 365-371

  Lerner, Uri ^a,b   Amram, Eytan ^a,b   Ayling, Roger D ^c   Mikula, Inna ^a   Gerchman, Irena ^a   Harrus, Shimon ^b   Teff, Dina ^b   Yogev, David ^b   Lysnyansky, Inna ^a  

^a KIMRON VETERINARY INSTITUTE   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Acquired resistance; Mycoplasma bovis; Tilmicosin; Tylosin

Indexed keywords

AMINO ACID; RIBOSOME PROTEIN; RNA 23S; TILMICOSIN; TYLOSIN;

ALLELE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIUM ISOLATE; BINDING SITE; CONTROLLED STUDY; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA BOVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; SEQUENCE ANALYSIS;

ESCHERICHIA COLI; MYCOPLASMA BOVIS;

ACQUIRED RESISTANCE; MYCOPLASMA BOVIS; TILMICOSIN; TYLOSIN;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CATTLE DISEASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA BOVIS; MYCOPLASMA INFECTIONS; POINT MUTATION; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL, 23S; TYLOSIN;

EID: 84892492920     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2015.11.005     Document Type: Erratum

References (35)

1. Andersen N.M., Poehlsgaard J., Warrass R., Douthwaite S. Inhibition of protein synthesis on the ribosome by tildipirosin compared with other veterinary macrolides. Antimicrob. Agents Chemother. 2012, 56:6033-6036.
2. Ayling R.D., Baker S.E., Peek M.L., Simon A.J., Nicholas R.A. Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against recent field isolates of Mycoplasma bovis. Vet. Rec. 2000, 146:745-747.
3. Bebear C., Pereyre S., Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 2011, 6:423-431.
4. Beeton M.L., Chalker V.J., Maxwell N.C., Kotecha S., Spiller O.B. Concurrent titration and determination of antibiotic resistance in Ureaplasma species with identification of novel point mutations in genes associated with resistance. Antimicrob. Agents Chemother. 2009, 53:2020-2027.
5. Diner E.J., Hayes C.S. Recombineering reveals a diverse collection of ribosomal proteins L4 and L22 that confer resistance to macrolide antibiotics. J. Mol. Biol. 2009, 386:300-315.
6. Gerchman I., Levisohn S., Mikula I., Lysnyansky I. In vitro antimicrobial susceptibility of Mycoplasma bovis isolated in Israel from local and imported cattle. Vet. Microbiol. 2009, 137:268-275.
7. Gerchman I., Levisohn S., Mikula I., Manso-Silvan L., Lysnyansky I. Characterization of in vivo-acquired resistance to macrolides of Mycoplasma gallisepticum strains isolated from poultry. Vet. Res. 2011, 42:90.
8. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids. Symp. Ser. 1999, 41:95-98.
9. Hannan P.C. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary Mycoplasma species. Vet. Res. 2000, 31:373-395.
10. Hansen J.L., Ippolito J.A., Ban N., Nissen P., Moore P.B., Steitz T.A. The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol. Cell 2002, 10:117-128.
11. Ito S., Shimada Y., Yamaguchi Y., Yasuda M., Yokoi S., Ito S.I., Nakano M., Ishiko H., Deguchi T. Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1g dose of azithromycin. Sex. Transm. Infect. 2011, 87.
12. Kobayashi H., Nakajima H., Shimizu Y., Eguchi M., Hata E., Yamamoto K. Macrolides and lincomycin susceptibility of Mycoplasma hyorhinis and variable mutation of domain II and V in 23S ribosomal RNA. J. Vet. Med. Sci. 2005, 67:795-800.
13. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 2002, 34:482-492.
14. Liu M., Douthwaite S. Resistance to the macrolide antibiotic tylosin is conferred by single methylations at 23S rRNA nucleotides G748 and A2058 acting in synergy. Proc. Natl. Acad. Sci. USA 2002, 99:14658-14663.
15. Lluch-Senar M., Luong K., Llorens-Rico V., Delgado J., Fang G., Spittle K., Clark T.A., Schadt E., Turner S.W., Korlach J., Serrano L. Comprehensive methylome characterization of Mycoplasma genitalium and Mycoplasma pneumoniae at single-base resolution. PLoS Genet. 2013, 9:e1003191.
16. Lu C., Ye T., Zhu G., Feng P., Ma H., Lu R., Lai W. Phenotypic and genetic characteristics of macrolide and lincosamide resistant Ureaplasma urealyticum isolated in Guangzhou, China. Curr. Microbiol. 2010, 61:44-49.
17. Luo W., Tu A.H., Cao Z., Yu H., Dybvig K. Identification of an isoschizomer of the HhaI DNA methyltransferase in Mycoplasma arthritidis. FEMS Microbiol. Lett. 2008, 290:195-198.
18. Nicholas R.A.J., Ayling R., McAuliffe L. Mycoplasma Diseases of Ruminants 2009, 300. CABI, Wallingford, UK.
19. Novotny G.W., Jakobsen L., Andersen N.M., Poehlsgaard J., Douthwaite S. Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA. Antimicrob. Agents Chemother. 2004, 48:3677-3683.
20. Pereyre S., Gonzalez P., De Barbeyrac B., Darnige A., Renaudin H., Charron A., Raherison S., Bebear C., Bebear C.M. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis. Antimicrob. Agents Chemother. 2002, 46:3142-3150.
21. Peric M., Bozdogan B.L., Jacobs M.R., Appelbaum P.C. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob. Agents Chemother. 2003, 47:1017-1022.
22. Poehlsgaard J., Andersen N.M., Warrass R., Douthwaite S. Visualizing the 16-membered ring macrolides tildipirosin and tilmicosin bound to their ribosomal site. ACS Chem. Biol. 2012, 7:1351-1355.
23. Prunier A.L., Trong H.N., Tande D., Segond C., Leclercq R. Mutation of L4 ribosomal protein conferring unusual macrolide resistance in two independent clinical isolates of Staphylococcus aureus. Microb. Drug Resist. 2005, 11:18-20.
24. Qi J., Guo A., Cui P., Chen Y., Mustafa R., Ba X., Hu C., Bai Z., Chen X., Shi L., Chen H. Comparative geno-plasticity analysis of Mycoplasma bovis HB0801 (Chinese isolate). PLoS One 2012, 7:e38239.
25. Razin A., Razin S. Methylated bases in mycoplasmal DNA. Nucleic Acids Res. 1980, 8:1383-1390.
26. Rosenbusch R.F., Kinyon J.M., Apley M., Funk N.D., Smith S.C., Hoffman L.J. In vitro antimicrobial inhibition profiles of Mycoplasma bovis isolates recovered from various regions of the United States from 2002 to 2003. J. Vet. Diagn. Invest. 2005, 17:436-441.
27. Rosengarten R., Behrens A., Stetefeld A., Heller M., Ahrens M., Sachse K., Yogev D., Kirchhoff H. Antigen heterogeneity among isolates of Mycoplasma bovis is generated by high-frequency variation of diverse membrane surface proteins. Infect. Immun. 1994, 62:5066-5074.
28. Shimada Y., Deguchi T., Nakane K., Yasuda M., Yokoi S., Ito S., Nakano M., Ishiko H. Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, Japan. Emerg. Infect. Dis. 2011, 17:1148-1150.
29. Stakenborg T., Vicca J., Butaye P., Maes D., Minion F.C., Peeters J., De Kruif A., Haesebrouck F. Characterization of in vivo acquired resistance of Mycoplasma hyopneumoniae to macrolides and lincosamides. Microb. Drug Resist. 2005, 11:290-294.
30. Tait-Kamradt A., Davies T., Appelbaum P.C., Depardieu F., Courvalin P., Petitpas J., Wondrack L., Walker A., Jacobs M.R., Sutcliffe J. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob. Agents Chemother. 2000, 44:3395-3401.
31. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28(10):2731-2739.
32. Thomas A., Nicolas C., Dizier I., Mainil J., Linden A. Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium. Vet. Rec. 2003, 153:428-431.
33. Wise K.S., Calcutt M.J., Foecking M.F., Roske K., Madupu R., Methe B.A. Complete genome sequence of Mycoplasma bovis type strain PG45 (ATCC 25523). Infect. Immun. 2011, 79:982-983.
34. Wojciechowski M., Czapinska H., Bochtler M. CpG underrepresentation and the bacterial CpG-specific DNA methyltransferase M.MpeI. Proc. Natl. Acad. Sci. USA 2013, 110:105-110.
35. Xiao L., Crabb D.M., Duffy L.B., Paralanov V., Glass J.I., Hamilos D.L., Waites K.B. Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp. Int. J. Antimicrob. Agents 2011, 37:377-379.